RE:RE:RE:RE:RE:RE:It's not about Tweed vs. Bedrocan Vs. Mettrum vs. also rans-I think you're right to be concerned by their expense levels. Sales of less than 1.5M$ is a greater concern IMO - but if they could sell something close to 7500Kg, or 60M$ in revenue, they would be in great shape. Current market cap is less than 100M$ - it could double or even triple with 60M$ revenue & over 20M$ gross profit. My concern is that sales at that level could be very hard to achieve while the injunction keeps the market oversupplied. -GLTA